that can cause actual results to differ materially from those described. Factors that may cause such differences include, but are not limited to, uncertainties relating to the acceptability of the Phase III clinical trial data by the FDA, our ability to successfully complete an FDA new drug application, acceptance of the new drug application by the FDA, approval by the FDA or other regulatory authorities of the current or future drug delivery system for the treatment of metastatic melanoma, our ability to successfully complete other clinical trials and secure regulatory approval of our current or future drug-delivery system for the treatment of other liver cancers and other organs, the potential of chemosaturation therapy via PHP as a treatment for patients with terminal metastatic disease in the liver, actions by the FDA or other regulatory agencies and uncertainties regarding our ability to obtain financial and other resources for any research, development and commercialization activities. These factors, and others, are discussed from time to time in our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements, which speak only as of the date they are made. We undertake no obligation to publicly update or revise these forward-looking statements to reflect events or circumstances after the date they are made.

(Date:3/30/2015)... 30, 2015 Heidrick & Struggles (Nasdaq: HSII ), ... consulting and culture shaping worldwide, today announced ... lead its global Healthcare and Life Sciences practice. ... Mitchell will lead a team of more than 80 partners, ... and Asia serving clients in ...

(Date:3/30/2015)... 2015 New Jersey Health Foundation, a not-for-profit organization ... of New Jersey , has committed ... announced James M. Golubieski , president. ... program, an additional $500,000 will be available for awards ... research projects that demonstrate exciting potential and may lead ...

... in the area of AIDS, geriatric diseases, neurosciences, and drug ... biotechnology reagents is projected to reach $32.5 billion by 2012. ... period is forecast to benefit protein related product markets in ... ...

... Melbourne-based Starfish,Ventures announced today the successful closure ... the largest venture capital fundraising in,Australia. The fund ... The success of this fundraising is an ... ability to foster the development of,innovative companies that, ...

(Date:3/20/2015)... , March 20, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market, ... is one of the products featured in 2015 "I ... at 11:00 PM EST on the DIY Network. ... Las Vegas , site of the 2015 ...

... the flatworm, planaria, offers new clues for understanding ... Institute have discovered how the worm's cells communicate ... scientists have found that gap-junction (microscopic tunnels directly ... This research, led by Dr. Michael Levin, underlies ...

... new computerized system to easilymonitor the levels of glucose ... study published today in the open access journal BMC ... that assists in the monitoring of glucose levels incritically ... moreefficient than the paper-based method currently used in manyintensive ...

... control what you eat and when, your nervous system ... contain information about energy level, food preferences, and metabolic ... of available food, determined by its smell and taste. ... path of olfactory signals beginning with chemical receptors in ...

... number is a new product ... Cornings product number. If showing ... under the old Sigma-Aldrich number ... for assistance. ID clarifier: filling ...

... system automates the denaturation and hybridization steps ... convenience for clinical and research personnel. The ... of sample types, is easy to use, ... 50% while ensuring overall precision and accuracy ...

... L1210 cells were cultured in DMEM and harvested ... order to keep the antigens in their native ... cells are arrayed on a 12-well (5 mm) ... treated to enhance cellular attachment and to minimize ...